Christopher “Chris” Stauffer, Allie Kaigle, Amy Lehrner, Leslie Morland
As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.
VA researchers Dr. Chris Stauffer and Dr. Amy Lehrner share insights on their pioneering studies of psychedelic-assisted therapy for PTSD, depression, and substance use in veterans, highlighting clinical models, set and setting, and peer support involvement.
Amy Lehrner, Christopher “Chris” Stauffer
Veterans, First Responders, and families supporting psychedelic medicine will be honored at the conference for their mental health challenges and the urgent need for better care and resources.
Itzel Barakat, Justin LaPree
Psychedelics show promise in treating pain and addiction. Psychedelic policy reform can inspire bipartisan coalitions and benefit drug policy reform overall.
Ethan Nadelmann
Session features the unlikely journey of psychedelic therapy into the VA and updates on current psychedelic research programs.
Marcus Capone, Amber Capone
Bob Parsons, a Vietnam War veteran and entrepreneur, advocates for psychedelic therapies to address PTSD. He shares how psychedelics helped him heal and is now helping other veterans.
Bob Parsons
Vicky Dulai of Compassion For Addiction moderates a discussion with Amy Emerson of MAPS Public Benefit Corporation and Rachel Yehuda of Icahn School of Medicine on leadership in the psychedelic
Rachel Yehuda
TREAT California initiative aims to transform mental healthcare in California with $5 Billion funding for psychedelic medicine research and access, inspired by successful stem cell agency model.
Jeannie Moller Fontana
